Catalyst Wire Dossier Catalyst Wire Dossier

TNF inhibitor

tumor necrosis factor inhibitor
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TNF inhibitor, covering 2012-02-24 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease [Phase 4]

See pricing